# Hypofractionated Radiotherapy With Concomitant Tumor Bed Boost for Breast Cancer

> **NCT06984250** · — · RECRUITING · sponsor: **National Taiwan University Hospital** · enrollment: 315 (estimated)

## Conditions studied

- Early Breast Cancer
- Ductal Breast Carcinoma In Situ

## Interventions

- **RADIATION:** Hypofractionated Radiation Therapy

## Key facts

- **NCT ID:** NCT06984250
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-06
- **Primary completion:** 2027-02-28
- **Final completion:** 2030-02-28
- **Target enrollment:** 315 (ESTIMATED)
- **Last updated:** 2025-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06984250

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06984250, "Hypofractionated Radiotherapy With Concomitant Tumor Bed Boost for Breast Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06984250. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*